Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 70

1.

Advances in endometrial cancer protein biomarkers for use in the clinic.

Martinez-Garcia E, Lopez-Gil C, Campoy I, Vallve J, Coll E, Cabrera S, Ramon Y Cajal S, Matias-Guiu X, Van Oostrum J, Reventos J, Gil-Moreno A, Colas E.

Expert Rev Proteomics. 2018 Jan;15(1):81-99. doi: 10.1080/14789450.2018.1410061. Epub 2017 Nov 30. Review.

PMID:
29183259
2.

Targeted Proteomics Identifies Proteomic Signatures in Liquid Biopsies of the Endometrium to Diagnose Endometrial Cancer and Assist in the Prediction of the Optimal Surgical Treatment.

Martinez-Garcia E, Lesur A, Devis L, Cabrera S, Matias-Guiu X, Hirschfeld M, Asberger J, van Oostrum J, Casares de Cal MLÁ, Gómez-Tato A, Reventos J, Domon B, Colas E, Gil-Moreno A.

Clin Cancer Res. 2017 Nov 1;23(21):6458-6467. doi: 10.1158/1078-0432.CCR-17-0474. Epub 2017 Aug 8.

3.

Tetraspanin microdomains control localized protein kinase C signaling in B cells.

Zuidscherwoude M, Dunlock VE, van den Bogaart G, van Deventer SJ, van der Schaaf A, van Oostrum J, Goedhart J, In 't Hout J, Hämmerling GJ, Tanaka S, Nadler A, Schultz C, Wright MD, Adjobo-Hermans MJW, van Spriel AB.

Sci Signal. 2017 May 9;10(478). pii: eaag2755. doi: 10.1126/scisignal.aag2755.

PMID:
28487417
4.

Development of a sequential workflow based on LC-PRM for the verification of endometrial cancer protein biomarkers in uterine aspirate samples.

Martinez-Garcia E, Lesur A, Devis L, Campos A, Cabrera S, van Oostrum J, Matias-Guiu X, Gil-Moreno A, Reventos J, Colas E, Domon B.

Oncotarget. 2016 Aug 16;7(33):53102-53115. doi: 10.18632/oncotarget.10632.

5.

Complexity reduction of clinical samples for routine mass spectrometric analysis.

Mesmin C, van Oostrum J, Domon B.

Proteomics Clin Appl. 2016 Apr;10(4):315-22. doi: 10.1002/prca.201500135. Epub 2016 Jan 22. Review.

PMID:
26680238
6.

Detecting Cytosolic Peptide Delivery with the GFP Complementation Assay in the Low Micromolar Range.

Schmidt S, Adjobo-Hermans MJ, Wallbrecher R, Verdurmen WP, Bovée-Geurts PH, van Oostrum J, Milletti F, Enderle T, Brock R.

Angew Chem Int Ed Engl. 2015 Dec 7;54(50):15105-8. doi: 10.1002/anie.201505913. Epub 2015 Oct 30.

PMID:
26515694
7.

Rapid transfer of overexpressed integral membrane protein from the host membrane into soluble lipid nanodiscs without previous purification.

Shirzad-Wasei N, van Oostrum J, Bovee-Geurts PH, Kusters LJ, Bosman GJ, DeGrip WJ.

Biol Chem. 2015 Aug;396(8):903-15. doi: 10.1515/hsz-2015-0100.

PMID:
25781680
8.

Productivity and quality of Dutch hospitals during system reform.

van Ineveld M, van Oostrum J, Vermeulen R, Steenhoek A, van de Klundert J.

Health Care Manag Sci. 2016 Sep;19(3):279-90. doi: 10.1007/s10729-015-9321-7. Epub 2015 Mar 15.

9.

Screening protein isoforms predictive for cancer using immunoaffinity capture and fast LC-MS in PRM mode.

Lesur A, Ancheva L, Kim YJ, Berchem G, van Oostrum J, Domon B.

Proteomics Clin Appl. 2015 Aug;9(7-8):695-705. doi: 10.1002/prca.201400158. Epub 2015 Mar 30.

PMID:
25656350
10.

Characterization of protein complexes using targeted proteomics.

Gomez YR, Gallien S, Huerta V, van Oostrum J, Domon B, Gonzalez LJ.

Curr Top Med Chem. 2014;14(3):344-50. Review.

PMID:
24304311
11.

Targeted proteomics strategy applied to biomarker evaluation.

Kim YJ, Gallien S, van Oostrum J, Domon B.

Proteomics Clin Appl. 2013 Dec;7(11-12):739-47. doi: 10.1002/prca.201300070. Epub 2013 Oct 31.

PMID:
24123942
12.

Large scale expression and purification of mouse melanopsin-L in the baculovirus expression system.

Shirzad-Wasei N, van Oostrum J, Bovee-Geurts PH, Wasserman M, Bosman GJ, Degrip WJ.

Protein Expr Purif. 2013 Oct;91(2):134-46. doi: 10.1016/j.pep.2013.07.010. Epub 2013 Aug 3.

PMID:
23921072
13.

Antibody-based proteomics: analysis of signaling networks using reverse protein arrays.

Voshol H, Ehrat M, Traenkle J, Bertrand E, van Oostrum J.

FEBS J. 2009 Dec;276(23):6871-9. doi: 10.1111/j.1742-4658.2009.07395.x. Epub 2009 Oct 26. Review.

14.

Report on the Barbados Workshop.

Ouellette S, Bell AW, van Oostrum J, Bergeron J.

Mol Cell Proteomics. 2009 Jun;8(6):1450-2. doi: 10.1074/mcp.H900006-MCP200. No abstract available.

15.

Tracing pathway activities with kinase inhibitors and reverse phase protein arrays.

van Oostrum J, Calonder C, Rechsteiner D, Ehrat M, Mestan J, Fabbro D, Voshol H.

Proteomics Clin Appl. 2009 Apr;3(4):412-22. doi: 10.1002/prca.200800070. Epub 2008 Dec 9.

PMID:
21136968
16.

A systematic review and meta-analysis of the effects of clinical pathways on length of stay, hospital costs and patient outcomes.

Rotter T, Kugler J, Koch R, Gothe H, Twork S, van Oostrum JM, Steyerberg EW.

BMC Health Serv Res. 2008 Dec 19;8:265. doi: 10.1186/1472-6963-8-265.

17.

A simulation model for determining the optimal size of emergency teams on call in the operating room at night.

van Oostrum JM, Van Houdenhoven M, Vrielink MM, Klein J, Hans EW, Klimek M, Wullink G, Steyerberg EW, Kazemier G.

Anesth Analg. 2008 Nov;107(5):1655-62. doi: 10.1213/ane.0b013e318184e919.

PMID:
18931229
18.

Fewer intensive care unit refusals and a higher capacity utilization by using a cyclic surgical case schedule.

Van Houdenhoven M, van Oostrum JM, Wullink G, Hans E, Hurink JL, Bakker J, Kazemier G.

J Crit Care. 2008 Jun;23(2):222-6. doi: 10.1016/j.jcrc.2007.07.002. Epub 2007 Dec 11.

PMID:
18538215
19.

Closing emergency operating rooms improves efficiency.

Wullink G, Van Houdenhoven M, Hans EW, van Oostrum JM, van der Lans M, Kazemier G.

J Med Syst. 2007 Dec;31(6):543-6.

PMID:
18041289
20.

LC-MALDI MS and MS/MS--an efficient tool in proteome analysis.

Mueller DR, Voshol H, Waldt A, Wiedmann B, Van Oostrum J.

Subcell Biochem. 2007;43:355-80. Review.

PMID:
17953403
21.

Biophotonics applied to proteomics.

Faupel M, Bonenfant D, Schindler P, Bertrand E, Mueller D, Stoeckli M, Bitsch F, Rohner T, Staab D, Van Oostrum J.

Subcell Biochem. 2007;43:323-38. Review.

PMID:
17953401
22.

Improving operating room efficiency by applying bin-packing and portfolio techniques to surgical case scheduling.

Van Houdenhoven M, van Oostrum JM, Hans EW, Wullink G, Kazemier G.

Anesth Analg. 2007 Sep;105(3):707-14.

PMID:
17717228
23.

Analysis of dynamic changes in post-translational modifications of human histones during cell cycle by mass spectrometry.

Bonenfant D, Towbin H, Coulot M, Schindler P, Mueller DR, van Oostrum J.

Mol Cell Proteomics. 2007 Nov;6(11):1917-32. Epub 2007 Jul 20.

24.

Letter 1: non-patient factors related to rates of ruptured appendicitis (Br J Surg 2007; 94: 214-221).

van Oostrum JM, Kazemier G.

Br J Surg. 2007 Jun;94(6):755; author reply 755-6. No abstract available.

PMID:
17514643
25.

Reduced susceptibility of Haemophilus influenzae to the peptide deformylase inhibitor LBM415 can result from target protein overexpression due to amplified chromosomal def gene copy number.

Dean CR, Narayan S, Richards J, Daigle DM, Esterow S, Leeds JA, Kamp H, Puyang X, Wiedmann B, Mueller D, Voshol H, van Oostrum J, Wall D, Koehn J, Dzink-Fox J, Ryder NS.

Antimicrob Agents Chemother. 2007 Mar;51(3):1004-10. Epub 2007 Jan 12.

26.

Identification of apolipoprotein A-I as a "STOP" signal for myopia.

Bertrand E, Fritsch C, Diether S, Lambrou G, Müller D, Schaeffel F, Schindler P, Schmid KL, van Oostrum J, Voshol H.

Mol Cell Proteomics. 2006 Nov;5(11):2158-66. Epub 2006 Aug 18.

27.

The application of systems biology to drug discovery.

Cho CR, Labow M, Reinhardt M, van Oostrum J, Peitsch MC.

Curr Opin Chem Biol. 2006 Aug;10(4):294-302. Epub 2006 Jul 5. Review.

PMID:
16822703
28.

Characterization of histone H2A and H2B variants and their post-translational modifications by mass spectrometry.

Bonenfant D, Coulot M, Towbin H, Schindler P, van Oostrum J.

Mol Cell Proteomics. 2006 Mar;5(3):541-52. Epub 2005 Nov 30.

29.

Evaluation of biomarker discovery approaches to detect protein biomarkers of acute renal allograft rejection.

Voshol H, Brendlen N, Müller D, Inverardi B, Augustin A, Pally C, Wieczorek G, Morris RE, Raulf F, van Oostrum J.

J Proteome Res. 2005 Jul-Aug;4(4):1192-9.

PMID:
16083269
30.

Neuroproteomics: expression profiling of the brain's proteomes in health and disease.

Kim SI, Voshol H, van Oostrum J, Hastings TG, Cascio M, Glucksman MJ.

Neurochem Res. 2004 Jun;29(6):1317-31. Review.

PMID:
15176488
31.

Proteomics-based target identification: bengamides as a new class of methionine aminopeptidase inhibitors.

Towbin H, Bair KW, DeCaprio JA, Eck MJ, Kim S, Kinder FR, Morollo A, Mueller DR, Schindler P, Song HK, van Oostrum J, Versace RW, Voshol H, Wood J, Zabludoff S, Phillips PE.

J Biol Chem. 2003 Dec 26;278(52):52964-71. Epub 2003 Oct 8.

32.

Proteomics in the discovery of new therapeutic targets for psychiatric disease.

Voshol H, Glucksman MJ, van Oostrum J.

Curr Mol Med. 2003 Aug;3(5):447-58. Review.

PMID:
12942998
33.

Functional expression of His-tagged rhodopsin in Sf9 insect cells.

Bosman GJ, van Oostrum J, Breikers G, Bovee-Geurts PH, Klaassen CH, DeGrip WJ.

Methods Mol Biol. 2003;228:73-86. No abstract available.

PMID:
12824545
34.
35.

Microfabricated polymer injector for direct mass spectrometry coupling.

Gobry V, van Oostrum J, Martinelli M, Rohner TC, Reymond F, Rossier JS, Girault HH.

Proteomics. 2002 Apr;2(4):405-12. Erratum in: Proteomics 2002 Oct;2(10):1474.

PMID:
12164699
36.

Preparative two-dimensional gel electrophoresis at alkaline pH using narrow range immobilized pH gradients.

Hoving S, Gerrits B, Voshol H, Müller D, Roberts RC, van Oostrum J.

Proteomics. 2002 Feb;2(2):127-34.

PMID:
11840558
37.

The human genome: proteomics.

Van Oostrum J, Voshol H.

Am J Psychiatry. 2002 Feb;159(2):208. No abstract available.

PMID:
11823260
38.

Fluoroaluminate stimulates phosphorylation of p130 Cas and Fak and increases attachment and spreading of preosteoblastic MC3T3-E1 cells.

Freitas F, Jeschke M, Majstorovic I, Mueller DR, Schindler P, Voshol H, Van Oostrum J, Susa M.

Bone. 2002 Jan;30(1):99-108.

PMID:
11792571
39.

Phosphorylation disrupts the central helix in Op18/stathmin and suppresses binding to tubulin.

Steinmetz MO, Jahnke W, Towbin H, García-Echeverría C, Voshol H, Müller D, van Oostrum J.

EMBO Rep. 2001 Jun;2(6):505-10.

40.

From proteomics to functional analysis.

van Oostrum J, Mueller D, Schindler P.

Novartis Found Symp. 2000;229:41-6; discussion 46-53. No abstract available.

PMID:
11084928
41.

Towards high performance two-dimensional gel electrophoresis using ultrazoom gels.

Hoving S, Voshol H, van Oostrum J.

Electrophoresis. 2000 Jul;21(13):2617-21.

PMID:
10949138
42.

Op18/stathmin caps a kinked protofilament-like tubulin tetramer.

Steinmetz MO, Kammerer RA, Jahnke W, Goldie KN, Lustig A, van Oostrum J.

EMBO J. 2000 Feb 15;19(4):572-80.

43.

Mass spectrometric characterization of stathmin isoforms separated by 2D PAGE.

Müller DR, Schindler P, Coulot M, Voshol H, van Oostrum J.

J Mass Spectrom. 1999 Apr;34(4):336-45.

PMID:
10226362
45.

Unique chemical reactivity of His-21 of CRM-197, a mutated diphtheria toxin.

Chang JY, Ramseier U, Hawthorne T, O'Reilly T, van Oostrum J.

FEBS Lett. 1998 May 15;427(3):362-6.

46.

Novel C5a receptor antagonists regulate neutrophil functions in vitro and in vivo.

Pellas TC, Boyar W, van Oostrum J, Wasvary J, Fryer LR, Pastor G, Sills M, Braunwalder A, Yarwood DR, Kramer R, Kimble E, Hadala J, Haston W, Moreira-Ludewig R, Uziel-Fusi S, Peters P, Bill K, Wennogle LP.

J Immunol. 1998 Jun 1;160(11):5616-21.

47.

Glyceraldehyde-3-phosphate dehydrogenase, the putative target of the antiapoptotic compounds CGP 3466 and R-(-)-deprenyl.

Kragten E, Lalande I, Zimmermann K, Roggo S, Schindler P, Muller D, van Oostrum J, Waldmeier P, Furst P.

J Biol Chem. 1998 Mar 6;273(10):5821-8.

48.

Neoepitope immunoassay: an assay for human interleukin 1 beta based on an antibody induced conformational change.

Towbin H, Erard F, van Oostrum J, Schmitz A, Rordorf C.

J Immunoassay. 1996 Nov;17(4):353-69.

PMID:
8957765
49.

Variation in N-linked carbohydrate chains in different batches of two chimeric monoclonal IgG1 antibodies produced by different murine SP2/0 transfectoma cell subclones.

Bergwerff AA, Stroop CJ, Murray B, Holtorf AP, Pluschke G, Van Oostrum J, Kamerling JP, Vliegenthart JF.

Glycoconj J. 1995 Jun;12(3):318-30.

PMID:
7496147

Supplemental Content

Loading ...
Support Center